Ultimovacs ASA (OSL:ZLNA)
Norway flag Norway · Delayed Price · Currency is NOK
17.80
-0.70 (-3.78%)
At close: Apr 1, 2025

Ultimovacs ASA Income Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
52.5361.4956.8447.4346.39
Upgrade
Other Operating Expenses
95.96151.48119.65113.775.04
Upgrade
Operating Expenses
151.26215.74179.13163.83124.15
Upgrade
Operating Income
-151.26-215.74-179.13-163.83-124.15
Upgrade
Interest Expense
-1.39-0.38-0.24-0.33-0.24
Upgrade
Interest & Investment Income
1.814.138.913.064.58
Upgrade
Currency Exchange Gain (Loss)
-12.757.18-3.62-0.75
Upgrade
Other Non Operating Income (Expenses)
10.62-0--00
Upgrade
EBT Excluding Unusual Items
-140.23-189.24-163.29-164.72-120.55
Upgrade
Impairment of Goodwill
-72.49----
Upgrade
Other Unusual Items
---4.5--
Upgrade
Pretax Income
-212.71-189.24-167.79-164.72-120.55
Upgrade
Income Tax Expense
-11.65----
Upgrade
Net Income
-201.06-189.24-167.79-164.72-120.55
Upgrade
Net Income to Common
-201.06-189.24-167.79-164.72-120.55
Upgrade
Shares Outstanding (Basic)
3434343230
Upgrade
Shares Outstanding (Diluted)
3434343230
Upgrade
Shares Change (YoY)
0.02%0.44%5.79%6.98%31.98%
Upgrade
EPS (Basic)
-5.84-5.50-4.90-5.09-3.98
Upgrade
EPS (Diluted)
-5.84-5.50-4.90-5.09-3.98
Upgrade
Free Cash Flow
-163.42-189.85-167.89-125.91-108.51
Upgrade
Free Cash Flow Per Share
-4.75-5.52-4.90-3.89-3.59
Upgrade
EBITDA
-148.49-214.85-178.19-162.83-123.16
Upgrade
D&A For EBITDA
2.770.890.941.010.99
Upgrade
EBIT
-151.26-215.74-179.13-163.83-124.15
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.